{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:10:13Z","timestamp":1782940213655,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00556136"],"award-info":[{"award-number":["RS-2025-00556136"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.joms.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:12:17Z","timestamp":1768407137000},"page":"769-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Does Drug Type Influence Surgical Outcome in MRONJ? A Comparison of Denosumab and Zoledronate"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-5059","authenticated-orcid":false,"given":"Jung-Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-9340","authenticated-orcid":false,"given":"Soo Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8040-7749","authenticated-orcid":false,"given":"Shin-Won","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1672-5730","authenticated-orcid":false,"given":"Jin-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-Related Osteonecrosis of the Jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent J"},{"key":"10.1016\/j.joms.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: a literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J Oral Biosci"},{"key":"10.1016\/j.joms.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","article-title":"Medication related osteonecrosis of the jaw: 2021 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"28","author":"Kim","year":"2021","journal-title":"J Bone Metab"},{"key":"10.1016\/j.joms.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.3390\/ijms23169465","article-title":"Current status of the diagnosis and management of osteoporosis","volume":"23","author":"Aibar-Almazan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.joms.2026.01.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100470","article-title":"Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis","volume":"39","author":"Lorange","year":"2023","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.joms.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.afos.2016.03.003","article-title":"Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis","volume":"2","author":"Benjamin","year":"2016","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.joms.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.oooo.2018.02.010","article-title":"Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw","volume":"125","author":"Higuchi","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.joms.2026.01.003_bib10","first-page":"e326","article-title":"Medication-Related Osteonecrosis of the Jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis","volume":"25","author":"Limones","year":"2020","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2026.01.003_bib11","first-page":"2341","article-title":"Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: A propensity score-matched analysis","volume":"30","author":"Ikesue","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.joms.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00198-023-06818-3","article-title":"Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: A multi-institutional retrospective cohort study in Taiwan","volume":"34","author":"Liu","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joms.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","article-title":"Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw?","volume":"75","author":"Park","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.4317\/medoral.25733","article-title":"Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis","volume":"28","author":"Munoz-Salgado","year":"2023","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.joms.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/SCS.0000000000009161","article-title":"Use of leukocyte-rich and platelet-rich fibrin (L-PRF) adjunct to surgical debridement in the treatment of stage 2 and 3 medication-related osteonecrosis of the jaw","volume":"34","author":"Yalcin-Ulker","year":"2023","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.joms.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","article-title":"Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: A critical review organized by the ECTS","volume":"107","author":"Anastasilakis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.joms.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ada.2018.72585","article-title":"Wound healing complications in oncological patients: Perspectives for cellular therapy","volume":"36","author":"Deptula","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.joms.2026.01.003_bib18","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.joms.2020.05.037","article-title":"Can surgical management improve resolution of medication-related osteonecrosis of the jaw at early stages? A prospective cohort Study","volume":"78","author":"Giudice","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.3390\/ijerph18168432","article-title":"The treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): a systematic review with a pooled analysis of only surgery versus combined protocols","volume":"18","author":"Di Fede","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.joms.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lary.20076","article-title":"Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: A Belgian case series","volume":"119","author":"Saussez","year":"2009","journal-title":"Laryngoscope"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239126000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239126000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:32:41Z","timestamp":1779913961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239126000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0278239126000352"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2026.01.003","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Drug Type Influence Surgical Outcome in MRONJ? A Comparison of Denosumab and Zoledronate","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}